| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 9.16e-06 | 20 | 136 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.02e-04 | 36 | 136 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | apolipoprotein receptor activity | 1.38e-04 | 3 | 136 | 2 | GO:0030226 | |
| GeneOntologyMolecularFunction | translation elongation factor activity | 3.24e-04 | 20 | 136 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 3.72e-04 | 50 | 136 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 4.65e-04 | 53 | 136 | 4 | GO:0016859 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.48e-07 | 20 | 133 | 5 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 2.03e-07 | 9 | 133 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 3.37e-07 | 10 | 133 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.13e-06 | 13 | 133 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.57e-06 | 14 | 133 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | RGPD4 TNIK ADCY10 NIBAN1 RGPD8 PIK3R3 RGPD1 PPP1R14A YES1 PLXNB2 EEF1A1 EEF1A2 MLXIPL KDM4D PTPRB NRXN1 RGPD3 PRKAR1A MAP3K11 PRMT2 PRKDC GNAS PHIP | 3.46e-06 | 1226 | 133 | 23 | GO:0042325 |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | RGPD4 TNIK ADCY10 NIBAN1 ABCA2 RGPD8 PIK3R3 RGPD1 PPP1R14A YES1 PLXNB2 EEF1A1 EEF1A2 MLXIPL KDM4D PTPRB NRXN1 RGPD3 PRKAR1A MAP3K11 PRMT2 PRKDC GNAS CAMTA1 PHIP | 3.82e-06 | 1421 | 133 | 25 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | RGPD4 TNIK ADCY10 NIBAN1 ABCA2 RGPD8 PIK3R3 RGPD1 PPP1R14A YES1 PLXNB2 EEF1A1 EEF1A2 MLXIPL KDM4D PTPRB NRXN1 RGPD3 PRKAR1A MAP3K11 PRMT2 PRKDC GNAS CAMTA1 PHIP | 3.91e-06 | 1423 | 133 | 25 | GO:0051174 |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | RGPD4 ADCY10 ABCA2 FMO2 RGPD8 RGPD1 POR BHMT MLXIPL RGPD3 LPGAT1 C1QTNF1 | 2.50e-05 | 434 | 133 | 12 | GO:0062012 |
| GeneOntologyBiologicalProcess | cellular response to glucagon stimulus | 7.15e-05 | 13 | 133 | 3 | GO:0071377 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.03e-04 | 38 | 133 | 4 | GO:0000413 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | RGPD4 TNIK ADCY10 NIBAN1 RGPD8 PIK3R3 RGPD1 YES1 EEF1A2 MLXIPL NRXN1 RGPD3 MAP3K11 GNAS CAMTA1 PHIP | 1.74e-04 | 879 | 133 | 16 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | RGPD4 TNIK ADCY10 NIBAN1 RGPD8 PIK3R3 RGPD1 YES1 EEF1A2 MLXIPL NRXN1 RGPD3 MAP3K11 GNAS CAMTA1 PHIP | 1.74e-04 | 879 | 133 | 16 | GO:0010562 |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 2.16e-04 | 249 | 133 | 8 | GO:0015931 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 2.35e-04 | 134 | 133 | 6 | GO:0010906 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 2.76e-04 | 195 | 133 | 7 | GO:0006606 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.14e-07 | 8 | 135 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.39e-07 | 10 | 135 | 4 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.58e-06 | 14 | 135 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 4.75e-06 | 18 | 135 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 7.44e-06 | 20 | 135 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 9.14e-06 | 21 | 135 | 4 | GO:0106068 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.04e-05 | 45 | 135 | 5 | GO:0044295 | |
| GeneOntologyCellularComponent | nuclear pore | 4.97e-05 | 101 | 135 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | interstitial matrix | 1.68e-04 | 17 | 135 | 3 | GO:0005614 | |
| GeneOntologyCellularComponent | pseudopodium | 2.00e-04 | 18 | 135 | 3 | GO:0031143 | |
| GeneOntologyCellularComponent | eukaryotic translation elongation factor 1 complex | 2.46e-04 | 4 | 135 | 2 | GO:0005853 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 RGPD8 TEX2 RGPD1 RRM2 MYORG NUP205 NRXN1 RGPD3 UGT2B15 LMNTD1 RGPD5 | 2.83e-04 | 560 | 135 | 12 | GO:0005635 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RGPD4 CERS2 FMO2 RGPD8 TEX2 CALHM1 COPB2 HLA-H RGPD1 POR MYORG GRAMD2A MIA2 DHH OTOF CANT1 SLC35D3 RGPD3 LPGAT1 UGT2B15 | 3.37e-04 | 1327 | 135 | 20 | GO:0042175 |
| GeneOntologyCellularComponent | nuclear membrane | 4.50e-04 | 349 | 135 | 9 | GO:0031965 | |
| GeneOntologyCellularComponent | actin cytoskeleton | AMPH TMEM63B ACTN1 ACTN2 NEB YES1 CDC42BPB EEF1A1 COBL NEURL1B KLHL17 | 1.30e-03 | 576 | 135 | 11 | GO:0015629 |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class I | 1.45e-03 | 9 | 135 | 2 | GO:0097651 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IA | 1.45e-03 | 9 | 135 | 2 | GO:0005943 | |
| MousePheno | increased hepatocellular carcinoma incidence | 1.66e-06 | 70 | 115 | 7 | MP:0003331 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 7.33e-06 | 16 | 115 | 4 | MP:0003701 | |
| MousePheno | increased hepatobiliary system tumor incidence | 3.56e-05 | 111 | 115 | 7 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 3.56e-05 | 111 | 115 | 7 | MP:0008019 | |
| MousePheno | abnormal morula morphology | 5.65e-05 | 26 | 115 | 4 | MP:0012058 | |
| MousePheno | decreased tumor latency | 1.01e-04 | 30 | 115 | 4 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 1.15e-04 | 31 | 115 | 4 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 1.67e-04 | 34 | 115 | 4 | MP:0010307 | |
| Domain | Grip | 8.17e-09 | 11 | 135 | 5 | SM00755 | |
| Domain | GRIP | 8.17e-09 | 11 | 135 | 5 | PF01465 | |
| Domain | Ran_BP1 | 1.39e-08 | 12 | 135 | 5 | PF00638 | |
| Domain | RANBD1 | 1.39e-08 | 12 | 135 | 5 | PS50196 | |
| Domain | GRIP_dom | 1.39e-08 | 12 | 135 | 5 | IPR000237 | |
| Domain | GRIP | 1.39e-08 | 12 | 135 | 5 | PS50913 | |
| Domain | RanBD | 2.25e-08 | 13 | 135 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 2.25e-08 | 13 | 135 | 5 | IPR000156 | |
| Domain | Rab_bind | 8.98e-08 | 7 | 135 | 4 | PF16704 | |
| Domain | GCC2_Rab_bind | 8.98e-08 | 7 | 135 | 4 | IPR032023 | |
| Domain | - | 5.30e-07 | 10 | 135 | 4 | 1.10.220.60 | |
| Domain | Transl_elong_EF1A_euk/arc | 5.19e-05 | 2 | 135 | 2 | IPR004539 | |
| Domain | CNH | 1.27e-04 | 14 | 135 | 3 | SM00036 | |
| Domain | IL-17_rcpt_C/E_N | 1.55e-04 | 3 | 135 | 2 | IPR027841 | |
| Domain | IL17_R_N | 1.55e-04 | 3 | 135 | 2 | PF15037 | |
| Domain | PI3K_P85_iSH2 | 1.55e-04 | 3 | 135 | 2 | IPR032498 | |
| Domain | PI3K_P85_iSH2 | 1.55e-04 | 3 | 135 | 2 | PF16454 | |
| Domain | CNH | 1.58e-04 | 15 | 135 | 3 | PF00780 | |
| Domain | CNH | 1.58e-04 | 15 | 135 | 3 | PS50219 | |
| Domain | CNH_dom | 1.58e-04 | 15 | 135 | 3 | IPR001180 | |
| Domain | SH3_1 | 1.91e-04 | 164 | 135 | 7 | PF00018 | |
| Domain | SH3_domain | 2.01e-04 | 220 | 135 | 8 | IPR001452 | |
| Domain | TPR-like_helical_dom | 2.96e-04 | 233 | 135 | 8 | IPR011990 | |
| Domain | PI3kinase_P85 | 5.11e-04 | 5 | 135 | 2 | IPR001720 | |
| Domain | EFhand_Ca_insen | 7.63e-04 | 6 | 135 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 7.63e-04 | 6 | 135 | 2 | IPR014837 | |
| Domain | TPR-contain_dom | 7.79e-04 | 150 | 135 | 6 | IPR013026 | |
| Domain | SH3 | 9.96e-04 | 216 | 135 | 7 | SM00326 | |
| Domain | SH3 | 9.96e-04 | 216 | 135 | 7 | PS50002 | |
| Domain | Ca_chan_IQ | 1.06e-03 | 7 | 135 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 1.06e-03 | 7 | 135 | 2 | PF08763 | |
| Domain | VDCC_a1su_IQ | 1.06e-03 | 7 | 135 | 2 | IPR014873 | |
| Domain | GPHH | 1.06e-03 | 7 | 135 | 2 | PF16905 | |
| Domain | GPHH_dom | 1.06e-03 | 7 | 135 | 2 | IPR031649 | |
| Domain | PH_dom-like | RGPD4 RGPD8 DOCK9 TBC1D2 RGPD1 CDC42BPB PLCD3 RGPD3 ARAP1 RGPD5 | 1.07e-03 | 426 | 135 | 10 | IPR011993 |
| Domain | TPR_REGION | 1.28e-03 | 165 | 135 | 6 | PS50293 | |
| Domain | TPR | 1.28e-03 | 165 | 135 | 6 | PS50005 | |
| Domain | Transl_elong_EFTu/EF1A_C | 1.41e-03 | 8 | 135 | 2 | IPR004160 | |
| Domain | GTP_EFTU_D3 | 1.41e-03 | 8 | 135 | 2 | PF03143 | |
| Domain | JMJC | 1.57e-03 | 32 | 135 | 3 | PS51184 | |
| Domain | JmjC_dom | 1.57e-03 | 32 | 135 | 3 | IPR003347 | |
| Domain | JmjC | 1.72e-03 | 33 | 135 | 3 | SM00558 | |
| Domain | G_TR_CS | 1.81e-03 | 9 | 135 | 2 | IPR031157 | |
| Domain | - | 2.17e-03 | 391 | 135 | 9 | 2.30.29.30 | |
| Domain | EGF | 2.22e-03 | 126 | 135 | 5 | PF00008 | |
| Domain | JmjN | 2.25e-03 | 10 | 135 | 2 | SM00545 | |
| Domain | JmjN | 2.25e-03 | 10 | 135 | 2 | PF02375 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 2.25e-03 | 10 | 135 | 2 | IPR009001 | |
| Domain | JMJN | 2.25e-03 | 10 | 135 | 2 | PS51183 | |
| Domain | VDCCAlpha1 | 2.25e-03 | 10 | 135 | 2 | IPR002077 | |
| Domain | JmjN | 2.25e-03 | 10 | 135 | 2 | IPR003349 | |
| Domain | PNT | 2.73e-03 | 11 | 135 | 2 | PS51433 | |
| Domain | SAM_PNT | 2.73e-03 | 11 | 135 | 2 | PF02198 | |
| Domain | Pointed_dom | 2.73e-03 | 11 | 135 | 2 | IPR003118 | |
| Domain | SAM_PNT | 2.73e-03 | 11 | 135 | 2 | SM00251 | |
| Pathway | BIOCARTA_CHREBP_PATHWAY | 6.13e-07 | 10 | 106 | 4 | MM1530 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 8.52e-06 | 18 | 106 | 4 | MM1549 | |
| Pathway | BIOCARTA_CHREBP_PATHWAY | 1.07e-05 | 19 | 106 | 4 | M22004 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.17e-05 | 40 | 106 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.32e-05 | 41 | 106 | 5 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.49e-05 | 42 | 106 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.68e-05 | 43 | 106 | 5 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.61e-05 | 47 | 106 | 5 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 3.20e-05 | 49 | 106 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 3.54e-05 | 50 | 106 | 5 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 3.90e-05 | 51 | 106 | 5 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 5.64e-05 | 55 | 106 | 5 | MM14917 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 6.62e-05 | 92 | 106 | 6 | MM14951 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 7.30e-05 | 58 | 106 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 7.30e-05 | 58 | 106 | 5 | MM14736 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 RGPD8 TEX2 DOCK9 PIK3R3 RGPD1 PPP1R14A ACTN1 CDC42BPB TRAK1 PIK3R2 RGPD3 MAP3K11 PHIP ARAP1 | 9.94e-05 | 649 | 106 | 15 | MM15690 |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.26e-04 | 65 | 106 | 5 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.19e-04 | 73 | 106 | 5 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 3.77e-04 | 82 | 106 | 5 | MM15394 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 4.20e-04 | 47 | 106 | 4 | M19708 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 4.21e-04 | 84 | 106 | 5 | MM14929 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 4.29e-04 | 20 | 106 | 3 | M39002 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 4.70e-04 | 86 | 106 | 5 | MM15413 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 4.98e-04 | 21 | 106 | 3 | MM15633 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 5.74e-04 | 22 | 106 | 3 | M903 | |
| Pathway | REACTOME_NEPHRIN_FAMILY_INTERACTIONS | 6.56e-04 | 23 | 106 | 3 | M913 | |
| Pathway | WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION | 8.43e-04 | 25 | 106 | 3 | M39574 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.00e-03 | 59 | 106 | 4 | M27218 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.11e-03 | 155 | 106 | 6 | M41808 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.77e-11 | 7 | 136 | 5 | 15710750 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 DOCK9 LAMA5 IDUA PLXNB2 CDC42BPB ABCA7 MYORG TRAK1 FANCA PLCD3 GRAMD2A CANT1 IL17RE HELZ2 NAV2 MAP3K11 COBL PRKDC ARAP1 KLHL17 | 2.22e-09 | 1105 | 136 | 21 | 35748872 |
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 7.76e-09 | 7 | 136 | 4 | 11353387 | |
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 30944974 | ||
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 7.76e-09 | 7 | 136 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 7.76e-09 | 7 | 136 | 4 | 17372272 | |
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 38657106 | ||
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 21205196 | ||
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 18949001 | ||
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 25187515 | ||
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 8603673 | ||
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 26632511 | ||
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 24403063 | ||
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 23818861 | ||
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 23536549 | ||
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 12191015 | ||
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 22821000 | ||
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 20682751 | ||
| Pubmed | RGPD4 CACNA1E RGPD8 RGPD1 ACTN1 ACTN2 FNBP1L NEB RNF17 EEF1A1 NUP205 EEF1A2 PHEX MIA2 NRXN1 RGPD3 KRT40 NAV2 ANTXR1 PRKDC ITIH6 GABPA RGPD5 | 9.59e-09 | 1442 | 136 | 23 | 35575683 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.55e-08 | 8 | 136 | 4 | 21670213 | |
| Pubmed | 1.55e-08 | 8 | 136 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.55e-08 | 8 | 136 | 4 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.55e-08 | 8 | 136 | 4 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.55e-08 | 8 | 136 | 4 | 28745977 | |
| Pubmed | TNIK DOCK9 CDC42BPB NRXN1 HELZ2 NAV2 CAMTA1 BAIAP3 KDM4B ARAP1 | 2.20e-08 | 225 | 136 | 10 | 12168954 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 2.78e-08 | 9 | 136 | 4 | 18394993 | |
| Pubmed | 2.78e-08 | 9 | 136 | 4 | 28100513 | ||
| Pubmed | 2.78e-08 | 9 | 136 | 4 | 17887960 | ||
| Pubmed | 2.78e-08 | 9 | 136 | 4 | 11553612 | ||
| Pubmed | 2.78e-08 | 9 | 136 | 4 | 10601307 | ||
| Pubmed | 2.78e-08 | 9 | 136 | 4 | 9733766 | ||
| Pubmed | 2.78e-08 | 9 | 136 | 4 | 28877029 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | RGPD4 CACNA1B CACNA1E RGPD8 TNC RPS9 RGPD1 EEF1A2 RGPD3 PRKAR1A | 2.82e-08 | 231 | 136 | 10 | 16452087 |
| Pubmed | 4.61e-08 | 10 | 136 | 4 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 4.61e-08 | 10 | 136 | 4 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 4.61e-08 | 10 | 136 | 4 | 8857542 | |
| Pubmed | 4.61e-08 | 10 | 136 | 4 | 21859863 | ||
| Pubmed | 7.23e-08 | 11 | 136 | 4 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 7.23e-08 | 11 | 136 | 4 | 35771867 | |
| Pubmed | 7.23e-08 | 11 | 136 | 4 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.56e-07 | 13 | 136 | 4 | 31427429 | |
| Pubmed | 2.33e-07 | 4 | 136 | 3 | 9501083 | ||
| Pubmed | 2.91e-07 | 164 | 136 | 8 | 32409323 | ||
| Pubmed | 2.95e-07 | 15 | 136 | 4 | 14697343 | ||
| Pubmed | 4.40e-07 | 118 | 136 | 7 | 21078624 | ||
| Pubmed | ACTN1 NEB CDC42BPB PIK3R2 DYRK1B NAV2 PRKAR1A MAP3K11 COBL PRKDC CPLANE1 MAP4K4 | 5.14e-07 | 486 | 136 | 12 | 20936779 | |
| Pubmed | CERS2 NIBAN1 ABCA2 DOCK9 RPS9 POR COLGALT1 ECH1 EEF1A1 NUP205 MGAT2 MIA2 HELZ2 PRKAR1A LPGAT1 MAP3K11 PRKDC GNAS | 7.53e-07 | 1168 | 136 | 18 | 19946888 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 1.16e-06 | 6 | 136 | 3 | 12827191 | |
| Pubmed | RGPD4 TNIK CACNA1E AMPD2 RGPD8 RGPD1 VIRMA CDC42BPB EEF1A1 EEF1A2 PBRM1 NRXN1 RGPD3 LRP1 PRKAR1A MAP4K4 | 1.24e-06 | 963 | 136 | 16 | 28671696 | |
| Pubmed | 1.55e-06 | 22 | 136 | 4 | 27717094 | ||
| Pubmed | RGPD4 TNIK CACNA1B AMPD2 AMPH RGPD8 TEX2 DOCK9 COPB2 RGPD1 POR NT5DC3 CDC42BPB NRXN1 RGPD3 PRKAR1A MAP4K4 | 2.41e-06 | 1139 | 136 | 17 | 36417873 | |
| Pubmed | BRK/Sik expression in the gastrointestinal tract and in colon tumors. | 3.23e-06 | 8 | 136 | 3 | 10430081 | |
| Pubmed | 4.26e-06 | 28 | 136 | 4 | 18067320 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RAB25 IL17REL PIK3R3 TMEM63B FNBP1L ECH1 CDC42BPB EEF1A2 PHKB PTPRB LRP1 ANTXR1 COBL KATNIP GNAS CAMTA1 BAIAP3 KDM4B ARAP1 | 5.75e-06 | 1489 | 136 | 19 | 28611215 |
| Pubmed | Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology. | 6.88e-06 | 10 | 136 | 3 | 20368620 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 7.36e-06 | 118 | 136 | 6 | 27377895 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 RGPD8 HDHD5 RPS9 COPB2 RGPD1 RRM2 EEF1A1 EEF1A1P5 NUP205 EEF1A2 MGAT2 TELO2 RGPD3 PRKDC GNAS RGPD5 | 8.83e-06 | 1257 | 136 | 17 | 37317656 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | RGPD8 TNC LAMA5 ACTN1 ACTN2 ECH1 EEF1A1 CDC123 COBL PRMT2 CPLANE1 | 1.36e-05 | 560 | 136 | 11 | 21653829 |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.49e-05 | 38 | 136 | 4 | 12791264 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | CERS2 PITHD1 AMPD2 NIBAN1 RPS9 COPB2 HLA-H LAMA5 POR COLGALT1 PLXNB2 NT5DC3 ZFPL1 EEF1A1 MGAT2 LRP1 GNAS MAP4K4 | 1.51e-05 | 1451 | 136 | 18 | 30550785 |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 34511598 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 15610184 | ||
| Pubmed | eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency. | 1.52e-05 | 2 | 136 | 2 | 30782564 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 35741005 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 23664615 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 17920451 | ||
| Pubmed | The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders. | 1.52e-05 | 2 | 136 | 2 | 30370994 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 26212729 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 34445520 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 17825975 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 22095224 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 11313993 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 19494712 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 38220433 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 19636410 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 27630312 | ||
| Pubmed | Effects of ablation of N- and R-type Ca(2+) channels on pain transmission. | 1.52e-05 | 2 | 136 | 2 | 12074836 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 21994938 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 7945283 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 32347192 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 22259056 | ||
| Pubmed | 1.56e-05 | 202 | 136 | 7 | 24639526 | ||
| Pubmed | 1.63e-05 | 13 | 136 | 3 | 29285303 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | CERS2 POR ACTN1 PLXNB2 VIRMA ZFPL1 NUP205 VPS52 MGAT2 PBRM1 MIA2 LRP1 LPGAT1 ANTXR1 PRKDC GNAS | 2.03e-05 | 1203 | 136 | 16 | 29180619 |
| Pubmed | 2.29e-05 | 86 | 136 | 5 | 37253089 | ||
| Pubmed | 2.57e-05 | 15 | 136 | 3 | 8812466 | ||
| Pubmed | RGPD4 RGPD8 RPS9 RGPD1 ACTN1 NEB EEF1A1 EEF1A1P5 EEF1A2 FBXO3 RGPD3 PRKDC RGPD5 | 2.88e-05 | 844 | 136 | 13 | 25963833 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | RAB25 RPS9 COPB2 TBC1D2 EEF1A1 NUP205 EEF1A2 FANCA KDM4D LRP2 KDM8 PRKDC | 3.43e-05 | 736 | 136 | 12 | 29676528 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AMPD2 TEX2 RRM2 VIRMA TRAK1 EEF1A1 EEF1A2 MLXIPL DYRK1B NAV2 COBL GNAS MAP4K4 | 3.53e-05 | 861 | 136 | 13 | 36931259 |
| Pubmed | 3.60e-05 | 156 | 136 | 6 | 29961565 | ||
| Pubmed | 4.14e-05 | 160 | 136 | 6 | 31678930 | ||
| Pubmed | 4.52e-05 | 99 | 136 | 5 | 27746211 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 30768638 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 19559761 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 38996073 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 11101506 | ||
| Pubmed | Arginine Methylation by PRMT2 Controls the Functions of the Actin Nucleator Cobl. | 4.54e-05 | 3 | 136 | 2 | 29689199 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 9030526 | ||
| Interaction | ADARB2 interactions | 7.26e-08 | 17 | 135 | 5 | int:ADARB2 | |
| Interaction | RGPD4 interactions | 3.01e-07 | 22 | 135 | 5 | int:RGPD4 | |
| Interaction | RGPD3 interactions | 6.93e-07 | 47 | 135 | 6 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 8.92e-07 | 49 | 135 | 6 | int:RGPD1 | |
| Interaction | RGPD2 interactions | 8.98e-07 | 27 | 135 | 5 | int:RGPD2 | |
| Interaction | CACNA1A interactions | 1.78e-06 | 123 | 135 | 8 | int:CACNA1A | |
| Interaction | RGPD5 interactions | 3.76e-06 | 96 | 135 | 7 | int:RGPD5 | |
| Interaction | FER1L6 interactions | 1.01e-05 | 7 | 135 | 3 | int:FER1L6 | |
| Interaction | RGPD8 interactions | 1.03e-05 | 74 | 135 | 6 | int:RGPD8 | |
| Interaction | RICTOR interactions | RGPD4 NIBAN1 RGPD8 RGPD1 ACTN1 VIRMA EEF1A1 NUP205 PBRM1 PROZ TELO2 CDC123 RGPD3 ANTXR1 PRKDC PHIP RGPD5 | 1.31e-05 | 759 | 135 | 17 | int:RICTOR |
| Interaction | TOP3B interactions | ABCA2 DOCK9 LAMA5 ACTN1 RRM2 IDUA YES1 PLXNB2 CDC42BPB ABCA7 MYORG TRAK1 FANCA PLCD3 GRAMD2A CANT1 IL17RE HELZ2 NAV2 MAP3K11 COBL PRKDC GNAS ARAP1 KLHL17 | 1.35e-05 | 1470 | 135 | 25 | int:TOP3B |
| Interaction | MTF1 interactions | 1.93e-05 | 123 | 135 | 7 | int:MTF1 | |
| Interaction | RAC1 interactions | TNIK DOCK9 POR FNBP1L YES1 PLXNB2 CDC42BPB EEF1A1 NUP205 VPS52 CDC123 PIK3R2 KRT40 LRP2 MAP3K11 ANTXR1 COBL GNAS MAP4K4 ARAP1 | 2.72e-05 | 1063 | 135 | 20 | int:RAC1 |
| Interaction | HLA-B interactions | 3.41e-05 | 239 | 135 | 9 | int:HLA-B | |
| Interaction | FGFR1OP2 interactions | 4.06e-05 | 94 | 135 | 6 | int:FGFR1OP2 | |
| Interaction | RHOF interactions | DOCK9 POR ACTN1 YES1 PLXNB2 CDC42BPB NUP205 VPS52 TELO2 CDC123 PIK3R2 ANTXR1 COBL PRKDC MAP4K4 | 4.63e-05 | 673 | 135 | 15 | int:RHOF |
| Interaction | UBXN6 interactions | 6.88e-05 | 325 | 135 | 10 | int:UBXN6 | |
| Interaction | RAN interactions | RGPD4 RAB25 RGPD8 RGPD1 VIRMA EEF1A1 NUP205 EEF1A2 CDC123 RGPD3 PRKAR1A RGPD5 | 8.61e-05 | 475 | 135 | 12 | int:RAN |
| Cytoband | 22q13.33 | 1.99e-04 | 38 | 136 | 3 | 22q13.33 | |
| GeneFamily | Actinins | 1.24e-04 | 4 | 83 | 2 | 1112 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.76e-04 | 24 | 83 | 3 | 485 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.87e-04 | 115 | 83 | 5 | 769 | |
| GeneFamily | Low density lipoprotein receptors | 1.57e-03 | 13 | 83 | 2 | 634 | |
| GeneFamily | ATP binding cassette subfamily A | 1.83e-03 | 14 | 83 | 2 | 805 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 7.38e-07 | 33 | 136 | 5 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 2.87e-06 | 43 | 136 | 5 | MM3857 | |
| Coexpression | GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP | 1.02e-05 | 200 | 136 | 8 | M5085 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP | 1.02e-05 | 200 | 136 | 8 | M4313 | |
| Coexpression | GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP | 1.02e-05 | 200 | 136 | 8 | M4327 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 8.54e-09 | 193 | 136 | 9 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.34e-09 | 195 | 136 | 9 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.34e-09 | 195 | 136 | 9 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-07 | 192 | 136 | 8 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.40e-07 | 192 | 136 | 8 | 2802fae55683345ff94a1ecf73b6fbee4f17481e | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-07 | 192 | 136 | 8 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-06 | 178 | 136 | 7 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.33e-06 | 179 | 136 | 7 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-06 | 183 | 136 | 7 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-06 | 183 | 136 | 7 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | P03|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.66e-06 | 185 | 136 | 7 | a07dbe1f76e40734a28826423a5cc64b8e56af5e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-06 | 118 | 136 | 6 | 8d96a4879b28979fa04fbaeffa271a6b9ecbe867 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 1.98e-06 | 190 | 136 | 7 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-06 | 190 | 136 | 7 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.12e-06 | 192 | 136 | 7 | e79f2253e084a9ab9afcaf7ec42a5012ade42d36 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-06 | 193 | 136 | 7 | 027e098ad018e782287f84eee0f77551018f2196 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-06 | 193 | 136 | 7 | c5463a87f20b3a7f7ffda677b2f5a0e9e49d6685 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-06 | 193 | 136 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-06 | 197 | 136 | 7 | 7caa2c86dc4d50b57a7db8f7278d1588282ad6db | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-06 | 197 | 136 | 7 | 951f18f326967206adbbfc422cce9eea3d2e0854 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.51e-06 | 197 | 136 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.60e-06 | 198 | 136 | 7 | 1282db321e27499d310339d6383974614e295a20 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.69e-06 | 199 | 136 | 7 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.69e-06 | 199 | 136 | 7 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT1_-_meso|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.99e-06 | 142 | 136 | 6 | 77fd145c1c500d580f70ac4e54c3fd879ecf0ab3 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 170 | 136 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 171 | 136 | 6 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 173 | 136 | 6 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 174 | 136 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.59e-05 | 174 | 136 | 6 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-05 | 174 | 136 | 6 | e5f12831187140e84b9a49e93b2376b9fefb1aec | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-05 | 176 | 136 | 6 | bd5c85b3a4fb88ffe156599f6d224aa7664a513a | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.81e-05 | 178 | 136 | 6 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 179 | 136 | 6 | 78fae47ec9bff4e0159a86a281e831d7f8ee925a | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-05 | 180 | 136 | 6 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-05 | 181 | 136 | 6 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.99e-05 | 181 | 136 | 6 | 091e7975badd1ffa463a8ec87908be20781ecfd6 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.05e-05 | 182 | 136 | 6 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-05 | 183 | 136 | 6 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.12e-05 | 183 | 136 | 6 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.18e-05 | 184 | 136 | 6 | 924400f47e6b2cdf7b0d538df75857935cf0209b | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 2.18e-05 | 184 | 136 | 6 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.18e-05 | 184 | 136 | 6 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 185 | 136 | 6 | 872720275789d249c9859de825a923803d458875 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-05 | 186 | 136 | 6 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.39e-05 | 187 | 136 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.39e-05 | 187 | 136 | 6 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-05 | 187 | 136 | 6 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 188 | 136 | 6 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.46e-05 | 188 | 136 | 6 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 188 | 136 | 6 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-05 | 189 | 136 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 2.54e-05 | 189 | 136 | 6 | 8030a353473da34ae92429f2d822171a2e94248f | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 2.54e-05 | 189 | 136 | 6 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.61e-05 | 190 | 136 | 6 | 18c020ca9a23399214133ec255ab870e0060f2e1 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-05 | 190 | 136 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.61e-05 | 190 | 136 | 6 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.61e-05 | 190 | 136 | 6 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 191 | 136 | 6 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 191 | 136 | 6 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 191 | 136 | 6 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.69e-05 | 191 | 136 | 6 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 2.69e-05 | 191 | 136 | 6 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-05 | 191 | 136 | 6 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-05 | 191 | 136 | 6 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-05 | 192 | 136 | 6 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.77e-05 | 192 | 136 | 6 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-05 | 192 | 136 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.85e-05 | 193 | 136 | 6 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.85e-05 | 193 | 136 | 6 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 193 | 136 | 6 | abdfb8b1dbdcb424042e21017a9e829fced4457e | |
| ToppCell | 18-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 2.85e-05 | 193 | 136 | 6 | 9f4ba9c29ab8071d57e4187085ec3a47ab61e968 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-05 | 194 | 136 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-05 | 195 | 136 | 6 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 3.02e-05 | 195 | 136 | 6 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-05 | 195 | 136 | 6 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 195 | 136 | 6 | eaadc79f53b1cb208c6f7999925f318e1378197f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 196 | 136 | 6 | a20a56d8997d6db2a10046c8801c619a379de83c | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.11e-05 | 196 | 136 | 6 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.11e-05 | 196 | 136 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.11e-05 | 196 | 136 | 6 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.11e-05 | 196 | 136 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.11e-05 | 196 | 136 | 6 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 197 | 136 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.20e-05 | 197 | 136 | 6 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-05 | 197 | 136 | 6 | 15a08b04acb1cb7e84aeb072c650ce07374181f5 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-05 | 197 | 136 | 6 | 71367bebc23d0e81f60f780d6b0ab3a1783ac014 | |
| ToppCell | PND14-Mesenchymal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-05 | 197 | 136 | 6 | 9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-05 | 197 | 136 | 6 | 0f9836554ace3f9d155ebafdd719aa26466ca44e | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.20e-05 | 197 | 136 | 6 | e239caae24f40564a24ad909754f5436f767ccdb | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.29e-05 | 198 | 136 | 6 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 | |
| ToppCell | proximal-Epithelial-Neuroendocrine|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.29e-05 | 198 | 136 | 6 | 5dea6078488d584513c0bdbf5bba54877310b54a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.29e-05 | 198 | 136 | 6 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.29e-05 | 198 | 136 | 6 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | proximal-Epithelial-Neuroendocrine-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.29e-05 | 198 | 136 | 6 | 00ccf3020667cf2130bc354b441b65c0b1b0e862 | |
| ToppCell | proximal-3-Epithelial-Neuroendocrine|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.29e-05 | 198 | 136 | 6 | a6bc043faf68468d46bac441cf7447c236c7bae4 | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.29e-05 | 198 | 136 | 6 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.29e-05 | 198 | 136 | 6 | 9f972f217d2c39d4c0f7d0d4227d0fffe8535b9d | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type | 3.29e-05 | 198 | 136 | 6 | cd8a26de6c1cb9c42635146bb7220dd1b41ee97d | |
| ToppCell | Control_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type | 3.29e-05 | 198 | 136 | 6 | 532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2 | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 8.75e-08 | 3 | 132 | 3 | DOID:0080463 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 7.52e-07 | 163 | 132 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | periodontitis | 7.77e-07 | 223 | 132 | 9 | EFO_0000649 | |
| Disease | glucose measurement | TNIK FNBP1L EEF1A2 CDC123 SLC35D3 MAP3K11 C1QTNF1 MAP3K15 ARAP1 | 5.59e-05 | 380 | 132 | 9 | EFO_0004468 |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 5.94e-05 | 3 | 132 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 1.18e-04 | 4 | 132 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 1.97e-04 | 5 | 132 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | bitter non-alcoholic beverage consumption measurement | 3.95e-04 | 32 | 132 | 3 | EFO_0010093 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 4.11e-04 | 7 | 132 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | duodenal ulcer, gastric ulcer | 4.11e-04 | 7 | 132 | 2 | EFO_0004607, EFO_0009454 | |
| Disease | uric acid measurement | TNIK XPNPEP2 FNBP1L FANCA MLXIPL SELENOO LRP2 MAP3K11 GNAS KDM4B | 4.33e-04 | 610 | 132 | 10 | EFO_0004761 |
| Disease | Alzheimer disease | 5.46e-04 | 8 | 132 | 2 | cv:C0002395 | |
| Disease | mean platelet volume | NIBAN1 TEX2 ETV7 ACTN1 CDC42BPB EEF1A1P5 FANCA MLXIPL MAP3K11 GNAS CAMTA1 PHIP ARAP1 | 6.76e-04 | 1020 | 132 | 13 | EFO_0004584 |
| Disease | Congenital adrenal hyperplasia | 7.00e-04 | 9 | 132 | 2 | C0001627 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 7.00e-04 | 9 | 132 | 2 | EFO_0600040 | |
| Disease | Metastatic melanoma | 1.84e-03 | 54 | 132 | 3 | C0278883 | |
| Disease | coffee consumption, cups of coffee per day measurement | 2.29e-03 | 16 | 132 | 2 | EFO_0004330, EFO_0006782 | |
| Disease | cathepsin L1 measurement | 2.29e-03 | 16 | 132 | 2 | EFO_0010619 | |
| Disease | body fat percentage, type 2 diabetes mellitus | 2.58e-03 | 17 | 132 | 2 | EFO_0007800, MONDO_0005148 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 3.23e-03 | 19 | 132 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | Bladder Neoplasm | 3.67e-03 | 140 | 132 | 4 | C0005695 | |
| Disease | skin pigmentation | 3.70e-03 | 69 | 132 | 3 | EFO_0003784 | |
| Disease | Malignant neoplasm of urinary bladder | 3.76e-03 | 141 | 132 | 4 | C0005684 | |
| Disease | Joubert syndrome 1 | 3.94e-03 | 21 | 132 | 2 | C4551568 | |
| Disease | gastric ulcer | 3.94e-03 | 21 | 132 | 2 | EFO_0009454 | |
| Disease | blood urea nitrogen measurement | 4.32e-03 | 452 | 132 | 7 | EFO_0004741 | |
| Disease | colorectal carcinoma (is_implicated_in) | 4.33e-03 | 22 | 132 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | otitis media (implicated_via_orthology) | 4.33e-03 | 22 | 132 | 2 | DOID:10754 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TLELEVGDWKDNRRY | 276 | Q0P6H9 | |
| RARKEYWENLRIASG | 346 | Q93088 | |
| VLEKDLYWDAAEARA | 331 | Q8NFU1 | |
| RRKSALALRWEAGIY | 836 | Q9Y2D5 | |
| ARRYLKVDFADIGWS | 371 | P12645 | |
| ILYARDAWLKEDGVI | 226 | P55345 | |
| GHLEAAVVLYKWDRR | 1121 | Q9Y6Y1 | |
| SRDRTVKEWDLGRAY | 441 | Q8NAA4 | |
| KGYEEWLLNEIRRLE | 376 | P12814 | |
| AEKGYEEWLLNEIRR | 381 | P35609 | |
| ALWVLLRKGYDRVSV | 456 | Q9H6X2 | |
| IERELNGYRAWIDKA | 376 | Q15878 | |
| AALKRGNREWYDRIL | 566 | O94812 | |
| RRYGSWRELAKALAS | 56 | Q6L9W6 | |
| GDTYVAASRWKLRLI | 1071 | Q8N7X0 | |
| DEAVRNITWALKRYG | 271 | Q5FYB1 | |
| YLISGADDRLVKIWD | 201 | P35606 | |
| DGDWLLAREVAVRYL | 166 | Q8IU99 | |
| GFSIVERYKALVRWI | 301 | Q86W34 | |
| FAGDALLALWRVERK | 96 | Q96PN6 | |
| LSIYGRSRDEWDKLA | 541 | Q01433 | |
| IERELNGYLEWIFKA | 381 | Q00975 | |
| TWADLEDRDGRVYAK | 21 | Q96G23 | |
| RWLERYEIDSLIGKG | 106 | Q9Y463 | |
| RGIWELLLKYREGRT | 976 | Q8IZY2 | |
| VGVKESDWLQYRDLA | 666 | P49418 | |
| VKAQIWDTAGLERYR | 61 | P57735 | |
| DGRAKYWVERAAKLF | 111 | Q99666 | |
| DGRAKYWVERAAKLF | 111 | O14715 | |
| GEFVEWLRRYLENGK | 186 | P01893 | |
| TRGLVAVLLYWDGKR | 126 | Q92621 | |
| RDVAGLYEEIWKADR | 266 | Q7Z304 | |
| KEDWIAYISREILRG | 126 | O95819 | |
| YRLGRVVDEWLLDKG | 221 | P58400 | |
| WQKAAGVAERYDILL | 1016 | P23467 | |
| VGRIEKVWVRDGAAY | 1176 | Q86U86 | |
| LDVKARLEGEINTYW | 376 | Q6A162 | |
| LRVLDSKRFWYIEGI | 46 | Q92604 | |
| EGKELYLSWVVEARR | 411 | P16435 | |
| EAGKLSYWVDRRRKA | 111 | Q6ZVW7 | |
| VWERVKILRDYAGLI | 241 | Q10469 | |
| EQVTRWAAALEGYRK | 161 | Q06546 | |
| WAAALEGYRKEQERL | 166 | Q06546 | |
| IKVRNYWTADGDLDI | 571 | O60303 | |
| NERLYWADAKLSVIG | 4056 | Q07954 | |
| ARESDGWYVLEKVDL | 321 | Q8NFR9 | |
| DVDKDWRRVYAIGCL | 86 | Q8N371 | |
| GFKAEWLAVKDERLY | 211 | Q8WVQ1 | |
| LDSRYWRITNAKGDV | 326 | Q9UK99 | |
| KFGSREWVLGRVEYD | 1176 | O15031 | |
| RVLYEWFLGKRSEGV | 91 | O75564 | |
| RWDGERLYQEARKIV | 436 | P05164 | |
| KGDDVARISWYLRDI | 131 | Q13011 | |
| ELVELRWTDGNLYKA | 981 | O94953 | |
| ERYDLWKRGQDRAVV | 331 | Q6B0I6 | |
| WINRREDKLGVYSLV | 6 | Q8N9Z9 | |
| LDGRYRKWLISTDLD | 4171 | P98164 | |
| WALRVEAEGVLLDYV | 996 | O15230 | |
| IIQWVSDEKDARGYL | 821 | Q9Y5S2 | |
| QWRYREASRKAEAIG | 391 | Q8TDS5 | |
| DVEKWIDGRLEELYR | 51 | Q96A00 | |
| YWGDISREEVNEKLR | 331 | O00459 | |
| YWGDISREEVNDKLR | 66 | Q92569 | |
| DGRAEYWVERAAKLF | 111 | A6NKT7 | |
| GEVKAELRKYWVRFL | 441 | O95838 | |
| YRAVLSWVKHDVDAR | 256 | Q6TDP4 | |
| VWVRLYKGERENAIF | 246 | Q9BXJ1 | |
| CADGLWKAERYELIA | 1721 | Q9BZ29 | |
| YIIEEDKGDGWTRAR | 566 | Q5T0N5 | |
| IDGRIADCRLLWDYV | 216 | Q9Y603 | |
| VFDIYRDSRGKVWLI | 231 | O75794 | |
| AEDYLLWKRLQGVSA | 2671 | Q9H799 | |
| LLARLAVEAGFDWVY | 161 | O43323 | |
| YAWVLDKLKAERERG | 56 | Q05639 | |
| YAWVLDKLKAERERG | 56 | P68104 | |
| AWAELLAGRVKREKY | 21 | O15360 | |
| LGIKELYAWDNRRET | 216 | O75128 | |
| ILRKVAWDYGRLALV | 61 | Q5T3F8 | |
| KALWEDEGVRACYER | 151 | P63092 | |
| YTRLRGISWKDEARV | 2151 | Q9BZC7 | |
| YWKAGDKEAAADRVR | 851 | Q02246 | |
| EWKDLVSSLARRYIG | 151 | P35475 | |
| EGAAVYRVFKRWRAV | 301 | A6NNE9 | |
| RRLWAYVTIGELLDA | 561 | Q6UXX5 | |
| YAWVLDKLKAERERG | 56 | Q5VTE0 | |
| WRFKENVEDGRASIY | 41 | Q99518 | |
| VKLWGIDRDSYRRIL | 221 | P10644 | |
| EREGLDWDLIYVGRK | 456 | Q8NBJ5 | |
| QRGELFSREDLVWYK | 2306 | Q9BYK8 | |
| STGELRLWDYRLLKV | 301 | Q8IUY3 | |
| VRRRIGAAYKLDDWA | 166 | Q3KP66 | |
| VYRGSWRGELVAVKA | 131 | Q16584 | |
| AAGAWALALAYRRID | 91 | Q93100 | |
| SKYRVEVLFWGLRDL | 1131 | Q9HC10 | |
| ARDWKRRYDVGISAA | 141 | O00398 | |
| TDGRAKYWVERAAKL | 101 | P0DJD0 | |
| ISVYVKLAGEREDLW | 66 | Q96PC5 | |
| YGQRTDKELIDWLRL | 1236 | Q6ZN16 | |
| LIGEYGLRNKREVWR | 31 | P46781 | |
| DGRAKYWVERAAKLF | 111 | Q7Z3J3 | |
| KDAYLEVWRLVRGTR | 386 | Q5M8T2 | |
| KLLREEAEGARWTSY | 81 | Q9UPQ4 | |
| VAYTARLDWKLAAEE | 486 | Q86VL8 | |
| SYIVGKDWRDLFDVV | 311 | Q86UY8 | |
| AERRGWAAPIRKLYA | 296 | Q9BXW7 | |
| WDVLDGVVRRLFKEY | 2051 | Q8IVL1 | |
| RIWDGVRKSSALAEY | 501 | Q9H0W8 | |
| ADWLQAYRARLDKDL | 556 | Q9BVL4 | |
| WEAALRALEGLVYRS | 531 | Q9Y4R8 | |
| ANDVLVRWKRAGSYL | 31 | P22891 | |
| AWILAAAEGRYEVLR | 116 | A6NJG2 | |
| EAVVLEGNYWKRRIE | 161 | Q9NP71 | |
| DQEEWKRRTGLLLYE | 351 | Q08AH1 | |
| ILDRRNVGIREKDYW | 1206 | Q96P48 | |
| VWLLKERGISAAVYD | 741 | Q9UPV9 | |
| DDGLWYRAKIVAIKE | 1491 | Q9BXT8 | |
| IAAKRDVPALDRYWE | 456 | Q8N1B4 | |
| KEEWIAYICREILRG | 126 | Q9UKE5 | |
| NDRKRTWLGLLEEAY | 266 | Q9BZQ8 | |
| VIVWDLARGVKIRSY | 491 | Q8WWQ0 | |
| LRWIGDKEATYGERV | 211 | P31350 | |
| KVFYIGLRGEWTELR | 166 | Q9GZP4 | |
| KERLYRLQEDGLSVW | 81 | Q8N3E9 | |
| ALLDRKEYWVVARAG | 361 | A8MQ27 | |
| LEWRNGKAAIDSYRI | 911 | P24821 | |
| AYRKWINDRRQGLEE | 656 | P78562 | |
| LRWVELAKLYRSIGE | 2921 | P78527 | |
| RDAVAVIRYLVWLEK | 371 | O43895 | |
| LEDSLLKILDRWIYG | 86 | P54855 | |
| ILYLFGRTGREKEEW | 686 | Q8IWB9 | |
| LGVWAKELNAREDYV | 196 | Q99633 | |
| TELLDLYREDRGAKW | 386 | Q69YN4 | |
| LYREDRGAKWVTALE | 391 | Q69YN4 | |
| DDDKYRRRPALGWLA | 231 | O95159 | |
| LLRVWDAFLYEGTKV | 806 | Q9BYX2 | |
| WDLRDQSVVRDLKGY | 406 | Q9H808 | |
| KGAYSLSIRDWDEIR | 191 | P07947 | |
| WALYGRAVDQDKVLR | 321 | Q6NSJ0 | |
| SDALYKADLEWLRGI | 3866 | P20929 |